|
× |
 |
Amisulpride: A Useful Second-Generation Antipsychotic Omitted From the US Residency Training Curriculum PDF |
$40.00 |
|
$40.00 |
|
× |
|
Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Low Hemoglobin Levels and Risk of Developing Depression in the Elderly: Results From the Prospective PRO.V.A. Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Antipsychotic Treatment on Tardive Dyskinesia: A 6-Month Evaluation of Patients From the European Schizophrenia Outpatient Health Outcomes (SOHO) Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long-Term Treatment PDF |
$40.00 |
|
$40.00 |
|
|
